Clinical use of the somatostatin analog SMS 201-995 in endocrinology.

Suppr

超能文献

作者信息

Cozzi R, Liuzzi A, Dallabonzana D, Oppizzi G, Orlandi P, De Palo C, Petroncini M M, Piolini M, Chiodini P G

机构信息

Divisione di Endocrinologia, Ospedale Niguarda, Milano, Italy.

出版信息

J Endocrinol Invest. 1988 Nov;11(10):737-40. doi: 10.1007/BF03350937.

DOI:10.1007/BF03350937

PMID:2852695

Abstract

摘要

相似文献

Clinical use of the somatostatin analog SMS 201-995 in endocrinology.

J Endocrinol Invest. 1988 Nov;11(10):737-40. doi: 10.1007/BF03350937.

Octreotide: a somatostatin analog.

Am Fam Physician. 1989 Jun;39(6):207-11.

NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.美国国立卫生研究院会议。生长抑素及生长抑素类似物（SMS 201-995）在治疗垂体及胃肠道激素分泌性肿瘤和肠道非肿瘤性疾病中的应用。

Ann Intern Med. 1989 Jan 1;110(1):35-50. doi: 10.7326/0003-4819-110-1-35.

Non-pituitary actions of somatostatin. A review on the therapeutic role of SMS 201-995 (sandostatin).

Acta Endocrinol Suppl (Copenh). 1986;276:41-55. doi: 10.1530/acta.0.111s0041.

[Therapeutic use of somatostatin analogues in endocrinology].[生长抑素类似物在内分泌学中的治疗应用]

Recenti Prog Med. 1992 Nov;83(11):626-33.

Endocrine applications of the somatostatin analogue octreotide (Sandostatin).

Metabolism. 1992 Sep;41(9 Suppl 2):34-8. doi: 10.1016/0026-0495(92)90028-9.

[Malignant insulinoma: lack of response to the somatostatin analog SMS 201-955].

Med Clin (Barc). 1989 Nov 25;93(17):676.

Clinical review 23: The use of the long-acting somatostatin analog octreotide in the treatment of gut neuroendocrine tumors.临床综述23：长效生长抑素类似物奥曲肽在肠道神经内分泌肿瘤治疗中的应用

J Clin Endocrinol Metab. 1991 Jul;73(1):1-3. doi: 10.1210/jcem-73-1-1.

Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature.

Digestion. 1989;42(2):116-20. doi: 10.1159/000199835.

[Clinical application of somatostatin-analogue].[生长抑素类似物的临床应用]

Nihon Rinsho. 1990 May;48(5):1084-8.

本文引用的文献

Somatostatin.生长抑素

N Engl J Med. 1983 Dec 15;309(24):1495-501. doi: 10.1056/NEJM198312153092406.

SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.SMS 201 - 995：一种非常强效且具选择性的生长抑素八肽类似物，作用持久。

Life Sci. 1982 Sep 13;31(11):1133-40. doi: 10.1016/0024-3205(82)90087-x.

Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses.

J Clin Endocrinol Metab. 1987 Jul;65(1):65-73. doi: 10.1210/jcem-65-1-65.

Somatostatin receptors in human endocrine tumors.人类内分泌肿瘤中的生长抑素受体

Cancer Res. 1987 Jan 15;47(2):551-8.

A guide to the clinical use of the somatostatin analogue SMS 201-995 (Sandostatin).

Acta Endocrinol Suppl (Copenh). 1987;286:54-66. doi: 10.1530/acta.0.115s054.

Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue.促甲状腺素分泌型垂体腺瘤对长效生长抑素类似物的反应

N Engl J Med. 1987 Jul 2;317(1):12-7. doi: 10.1056/NEJM198707023170103.

Medical treatment of acromegaly with SMS 201-995, a somatostatin analog: a comparison with bromocriptine.使用生长抑素类似物SMS 201-995对肢端肥大症进行药物治疗：与溴隐亭的比较。

J Clin Endocrinol Metab. 1987 Mar;64(3):447-53. doi: 10.1210/jcem-64-3-447.

Hyperthyroidism due to non-tumoural inappropriate TSH secretion. Effect of a long-acting somatostatin analogue (SMS 201-995).非肿瘤性不适当促甲状腺激素分泌所致甲状腺功能亢进。长效生长抑素类似物（SMS 201-995）的作用

Acta Endocrinol (Copenh). 1986 Sep;113(1):42-6.

Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.恶性类癌综合征的治疗。一种长效生长抑素类似物的评估。

N Engl J Med. 1986 Sep 11;315(11):663-6. doi: 10.1056/NEJM198609113151102.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验